Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

44 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 [14c]-rpc1063 solution (0.1 mg/ml) for oral administration - - - - 3件: 13, 96, 97 💬
2 Administration - - - - 1件: 19 💬
3 Administration of a high dose of desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件: 156 💬
4 Administration of a low dose of desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件: 156 💬
5 Administration of an ace-inhibitor or not - - - - 1件: 210 💬
6 Administration of cimzia® - - - - 1件: 46 💬
7 Administration of drug (interferon-gamma 1-b) subcutaneously - - - - 1件: 65 💬
8 Administration of rituximab and methylprednisolone Methylprednisolone 7件: D00407, D00751, D00979, D02994, D05000, D05001, D05002 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 51 💬
9 Administration of stable isotope-labelled leucine- Leucine 1件: D00030 💬 - - 1件:  6  💬
10 Avandia administration for 6-12 weeks - - - - 1件: 265 💬
11 Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus) Lactobacillus acidophilus 1件: D04349 💬 - - 1件: 97 💬
12 Biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml) Human immunoglobulin G - - - 1件: 14 💬
13 Biological: kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml) Human immunoglobulin G - - - 1件: 14 💬
14 Bosentan administration Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
15 Device: administration kit - - - - 1件: 19 💬
16 Device: nirs after bosentan administration Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
17 Device: tcd after bosentan administration Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
18 Docosahexaenoic acid administration: 50 mg/kg/day during 12 months Doconexent - - - 1件: 299 💬
19 Growth hormone administration for 6 months Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
20 Human normal 10% immunoglobulin for intravenous administration - - - - 1件: 14 💬
21 Human normal 10% immunoglobulin for intravenous administrationn - - - - 1件: 14 💬
22 Human normal immunoglobulin for intravenous (iv) administration Human immunoglobulin G - - - 1件: 51 💬
23 Human normal immunoglobulin for intravenous administration Human immunoglobulin G - - - 3件: 14, 51, 65 💬
24 Human normal immunoglobulin for subcutaneous administration Human immunoglobulin G - - - 2件: 51, 65 💬
25 Human normal immunoglobulin for subcutaneous administration (igsc) Human immunoglobulin G - - - 1件: 65 💬
26 Intrathecal administration of autologous msc-np - - - - 1件: 13 💬
27 Intravenous administration of 1 million of msc - - - - 1件:  2  💬
28 Intravenous administration of 2 million of msc - - - - 1件:  2  💬
29 Intravenous administration of 4 million of msc - - - - 1件:  2  💬
30 Intravenous administration of ferric carboxymaltose Ferric carboxymaltose 1件: D08920 💬 - - 1件: 86 💬
31 Levodopa (drug), intraduodenal administration Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
32 Levodopa and carbidopa solution for sc administration Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
33 Low-dose il-2 administration Human interleukin-2 - - - 1件: 96 💬
34 Methotrexate + biologic administration Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
35 Methotrexate + salazopyrine + hydroxychloroquine administration Hydroxychloroquine 3件: D00142, D02115, D08050 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
36 Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
37 Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
38 Other: questionnaire administration - - - - 4件: 16, 34, 51, 298 💬
39 Other: tobramycin time of administration Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
40 Procedure: iv administration of genetically engineered hematopoietic stem/progenitors cells (hspcs) - - - - 1件: 285 💬
41 Qr-313 gel for topical (cutaneous) administration - - - - 1件: 36 💬
42 Raav1-cmv-gaa (study agent) administration - - - - 1件: 256 💬
43 Semi continuous intra-oral administration of ld/cd - - - - 1件:  6  💬
44 Subcutanious administration - - - - 1件: 46 💬

先頭へ